Literature DB >> 4788211

Influence of allopurinol on drug metabolism in man.

M D Rawlins, S E Smith.   

Abstract

1. Elimination rates of phenylbutazone and warfarin after single oral doses in human volunteers, and steady-state plasma concentrations of these drugs in patients have been measured before, during and after administration of allopurinol.2. Allopurinol, in usual clinical doses, had no significant influence on the elimination rate of either drug in the group of volunteers as a whole although in a few individuals an apparent inhibitory effect was observed.3. No significant changes in the steady-state plasma concentrations of either phenylbutazone or warfarin were observed in patients during the administration of allopurinol.4. It is concluded that although allopurinol may have an apparent inhibitory effect on drug elimination in a few individuals, its administration to most patients on anticoagulant therapy is unlikely to alter dose requirements.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4788211      PMCID: PMC1776152          DOI: 10.1111/j.1476-5381.1973.tb08258.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  The plasma half lives and the pharmacological effect of the enantiomers of warfarin in rats.

Authors:  A Breckenridge; M L Orme
Journal:  Life Sci II       Date:  1972-04-08

2.  Allopurinol: alteration in pyrimidine metabolism in man.

Authors:  W N Kelley; T D Beardmore
Journal:  Science       Date:  1970-07-24       Impact factor: 47.728

3.  The metabolic fate of warfarin: studies on the metabolites in plasma.

Authors:  R J Lewis; W F Trager
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

4.  Increased rate of tolbutamide metabolism in alcoholic patients.

Authors:  R M Kater; F Tobon; F L Iber
Journal:  JAMA       Date:  1969-01-13       Impact factor: 56.272

5.  Impairment of drug metabolism in man by allopurinol and nortriptyline.

Authors:  E S Vesell; G T Passananti; F E Greene
Journal:  N Engl J Med       Date:  1970-12-31       Impact factor: 91.245

6.  Rapid fluorometric assay for plasma warfarin.

Authors:  M Corn; R Berberich
Journal:  Clin Chem       Date:  1967-02       Impact factor: 8.327

7.  Genetic control of phenylbutazone metabolism in man.

Authors:  J A Whittaker; D A Evans
Journal:  Br Med J       Date:  1970-11-07

8.  Orotidinuria induced by allopurinol.

Authors:  R M Fox; D Royse-Smith; W J O'Sullivan
Journal:  Science       Date:  1970-05-15       Impact factor: 47.728

9.  Studies on the coordinate activity and liability of orotidylate phosphoribosyltransferase and decarboxylase in human erythrocytes, and the effects of allopurinol administration.

Authors:  R M Fox; M H Wood; W J O'Sullivan
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

10.  Genetic control of drug levels in man: phenylbutazone.

Authors:  E S Vesell; J G Page
Journal:  Science       Date:  1968-03-29       Impact factor: 47.728

View more
  5 in total

1.  Interaction of allopurinol with phenprocoumon in man.

Authors:  E Jähnchen; I Meinertz; H J Gilfrich
Journal:  Klin Wochenschr       Date:  1977-08-01

Review 2.  Anticoagulants in older patients. A safety perspective.

Authors:  R J Beyth; C S Landefeld
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

3.  Acute adverse reactions attributed to allopurinol in hospitalised patients.

Authors:  G T McInnes; D H Lawson; H Jick
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

Review 4.  Pharmacokinetic drug interactions with theophylline.

Authors:  J H Jonkman; R A Upton
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

5.  Analysis of potential interactions between warfarin and prescriptions in Estonian outpatients aged 50 years or more.

Authors:  Maia Gavronski; Sirpa Hartikainen; Alexander Zharkovsky
Journal:  Pharm Pract (Granada)       Date:  2012-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.